APA (7th ed.) Citation

Tian, M., Wei, J. S., Shivaprasad, N., Highfill, S. L., Gryder, B. E., Milewski, D., . . . Khan, J. (2024). Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma. Cell reports. Medicine, 5(5), 101586. https://doi.org/10.1016/j.xcrm.2024.101586

Chicago Style (17th ed.) Citation

Tian, Meijie, et al. "Preclinical Development of a Chimeric Antigen Receptor T cell Therapy Targeting FGFR4 in Rhabdomyosarcoma." Cell Reports. Medicine 5, no. 5 (2024): 101586. https://doi.org/10.1016/j.xcrm.2024.101586.

MLA (9th ed.) Citation

Tian, Meijie, et al. "Preclinical Development of a Chimeric Antigen Receptor T cell Therapy Targeting FGFR4 in Rhabdomyosarcoma." Cell Reports. Medicine, vol. 5, no. 5, 2024, p. 101586, https://doi.org/10.1016/j.xcrm.2024.101586.